Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. KGaA
FME
XET
: FME
| ISIN: DE0005785802
14/04/2026
39,65 EUR
(-0,92%)
(-0,92%)
14/04/2026
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Technische analyse
TA
1 dag
1d
-0,92%
1 week
1w
1,38%
1 maand
1m
-0,70%
3 maanden
3m
7,25%
6 maanden
6m
-15,64%
1 jaar
1j
-9,00%
5 jaar
5j
-37,20%
Fresenius Medical Care AG & Co. KGaA in het nieuws
Toon enkel gratis nieuws
24 februari 2026 ·
Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band
· Persbericht
9 januari 2026 ·
Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned
· Persbericht
10 december 2025 ·
Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board
· Persbericht
4 november 2025 ·
Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025
· Persbericht
30 oktober 2025 ·
Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025
· Persbericht
1 oktober 2025 ·
Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement
· Persbericht
18 september 2025 ·
Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment
· Persbericht
11 augustus 2025 ·
Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework
· Persbericht
5 augustus 2025 ·
Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025
· Persbericht
31 juli 2025 ·
Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care
· Persbericht
Meer nieuws
Aandeel volgen
Aandeel gevolgd
Profiel Fresenius Medical Care AG & Co. KGaA
Gezondheidszorg
Gezondheidszorg en sociale bijstand
Medische/verpleegkundige diensten
Nierdialyse Centra
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe